Medivir AB (LTS:0GP7)
kr 2.92669 0 (0%) Market Cap: 364.55 Mil Enterprise Value: 208.56 Mil PE Ratio: 0 PB Ratio: 2.09 GF Score: 47/100

Q2 2022 Medivir AB Earnings Call Transcript

Aug 19, 2022 / 12:00PM GMT
Release Date Price: kr8.05
Operator

Welcome to Medivir's Quarter 2 Report 2022. (Operator Instructions) Today, I'm pleased to present CEO, Jens Lindberg; and CFO, Magnus Christensen; and CSO, Fredrik Ãberg. Please begin your meeting.

Jens Lindberg;publ;CEO
Medivir AB

()-

Thank you, operator. And we can immediately move to Slide 2, just for some further sort of color on who we are. So on the call, myself, and I have been CEO since January this year. And then Magnus, our CFO; and Fredrik, our CSO, will be sharing the presentations, and we'll be sort of sharing the Q&A session at the end of the call as well.

So with that, we can move to Slide 3, please. Important slide, you please access the slides on our website and you can read it there in a bit more detail and we'll jump forward.

And we can jump ahead to Slide #5, please, operator, in terms of highlights during last quarter, and we'll divide things into sort of 2 categories: one, focused on our lead asset, fostrox, and the other with regards to the other portfolio development.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot